WHAM Announces 2025 Edge Awards to Fund Early-Career Researchers in Women's Health

The 2025 WHAM Edge Awards represent a strategic intervention in women's health research funding, targeting early-career investigators who explore how biological sex influences health outcomes across autoimmune disease, brain health, cancer, and heart health. This initiative by WHAM (Women's Health Access Matters) addresses a critical funding gap where promising research ideas often stall due to traditional grantmaking requirements for preliminary data that junior investigators haven't yet collected. The awards expand to include emerging priorities such as healthspan, bone and muscle health, novel approaches to conditions like endometriosis and menopause, and innovative methodologies including AI and secondary data analysis.

Dr. Anula Jayasuriya, Chief Scientific Officer of WHAM, emphasized the program's significance, stating that early investment in bold ideas and brilliant minds drives progress in women's health. The WHAM Research Collaborative, comprising over 100 scientists and physicians from leading institutions, nominates candidates for these awards, with selection conducted by WHAM's Scientific Advisory Board including experts from Harvard Medical School, Yale, Northwestern University, and other prestigious institutions. Each awardee receives $25,000 in unrestricted funding for pre-clinical, clinical, or translational research, with recipients notified on October 29, 2025, and honored during a virtual WHAM Forum on November 18, 2025.

The initiative's importance stems from the documented disparity in research focus and funding. Most serious diseases affect women differently or disproportionately, yet research historically treated men as the default. Carolee Lee, Founder & CEO of WHAM, highlighted that women are greatly understudied and often disproportionately affected by diseases including lung cancer, heart disease, and Alzheimer's. WHAM's research demonstrates that investing $350 million in women's health research generates a $14 billion return to the U.S. economy, making it both an urgent health priority and a smart economic investment. The WHAM Investigator's Fund catalyzes private support for cutting-edge research, ensuring that women's health and the next generation of leaders have resources to thrive. For more information, visit https://www.whamnow.org.